Stem cells and cell therapies in lung biology and lung diseases

Keyphrases

• Cell Therapy 100%
• Stem Cells 100%
• Lung Disease 100%
• Lung Biology 100%
• Vermont 50%
• Mesenchymal Stem Cells 50%
• Lung 41%
• Lung Repair 41%
• Endothelial Progenitor Cells 33%
• Fibrotic Lung Disease 33%
• School of Medicine 33%
• University of Toronto 33%
• Progenitor Cells 25%
• Mouse Model 25%
• Therapy Approaches 25%
• Stem Cell Population 25%
• Bioengineering Techniques 25%
• Clinical Trials 16%
• Cell-based 16%
• Pulmonary Hypertension 16%
• University Schools 16%
• Pulmonary Fibrosis 16%
• University of Colorado 16%
• Heart Blood 16%
• Heart-lung 16%
• Human Embryonic Stem Cells (hESCs) 16%
• Crohn's Disease 16%
• Lung Cancer Stem Cells 16%
• National Heart 16%
• Lineage Tracing 16%
• Isolated Cells 16%
• Duke University 16%
• Health Sciences Center 16%
• Endogenous Progenitor Cells 16%
• Human Endothelial Progenitor Cells 16%
• Endogenous Stem Cells 16%
• Lung Regeneration 16%
• Immune-mediated Lung Disease 16%
• Microenvironmental Niche 16%
• Lung Progenitor Cells 16%
• Stem Cell Research 8%
• China 8%
• United States 8%
• Lung Tissue 8%
• Respiratory Disease 8%
• Translational Research 8%
• Pathophysiology 8%
• Graft-versus-host Disease (GvHD) 8%
• Immunomodulation 8%
• Regeneration 8%
• Lung Inflammation 8%
• Phase II Trial 8%
• University of Pennsylvania 8%
• Octamer-binding Transcription Factor 4 (OCT4) 8%
• Stem Cell Niche 8%
• Phase II Clinical Trial 8%
• Lessons Learned 8%
• Lung Cancer 8%
• Boston 8%
• Systems Approach 8%
• Lung Injury 8%
• Muscle Disease 8%
• Engraftment 8%
• University of Pittsburgh 8%
• Pathologic 8%
• Acute Lung Injury 8%
• Human Lung 8%
• Immunomodulatory Effect 8%
• Physiologic 8%
• Immune Cells 8%
• Cell Population 8%
• Cellular Repair 8%
• University of Texas 8%
• U.S. Food 8%
• Immune Signaling 8%
• Pulmonary Vascular 8%
• Airway Epithelium 8%
• University of Michigan 8%
• Microenvironment 8%
• Potential Therapeutics 8%
• Phase 1 Trial 8%
• Biologic Activity 8%
• Johns Hopkins University 8%
• Putative Drug Targets 8%
• Cystic Fibrosis Foundation 8%
• Complex Networks 8%
• Yale University 8%
• Limited Information 8%
• Experimental Protocol 8%
• Suppression Effect 8%
• National Institutes of Health 8%
• Embryoid Body 8%
• Pulmonary Vasculature 8%
• Mouse Lung 8%
• Knowledge Level 8%
• Alveolar Epithelium 8%
• Histomorphometry 8%
• Working Definition 8%
• Functional Assay 8%
• Developmental Potential 8%
• Cell-Associated 8%
• Lung Development 8%
• American Thoracic Society 8%
• Traditional View 8%
• Stem Cell Activation 8%
• Spatial Cues 8%
• Physical Environment 8%
• Clara Cell 8%
• Cell Effects 8%
• Adult Stem Cells 8%
• Human Embryonic Stem Cell Lines 8%
• Weiss 8%
• State of the Field 8%
• Three-dimensional Matrix 8%
• Treatment-resistant Patients 8%
• Rare Occurrence 8%
• Side Population Cells 8%
• Adult Lung 8%
• Duncan 8%
• Clara Cell Protein 8%
• Expansion Property 8%
• Stem Cell Progenitors 8%
• Stem Cell Potential 8%
• Tracing Studies 8%
• Indiana University 8%
• Immune-mediated Diseases 8%
• Fibrocytes 8%
• Wellington 8%
• Investigative Approach 8%
• Embryonic Origin 8%
• Boston Children's Hospital 8%
• 3D Culture System 8%
• Stem Cell Regeneration 8%
• Michelson 8%
• Patient Model 8%
• Cancer Progenitor Cells 8%
• Tracheal Repair 8%
• Positional Cue 8%
• Funding Priorities 8%
• Bronchioalveolar Stem Cells 8%
• Amniotic Mesenchymal Stem Cells 8%
• Circulating Fibrocytes 8%
• Functional Lung 8%
• Temporal Niche 8%
• Zhejiang University 8%
• Rosenzweig 8%
• Endogenous Progenitors 8%
• Expansion Area 8%
• Phenotypic Characteristics 8%
• Systems-based 8%
• Neonatal Mice 8%
• Alveolar Epithelial Type II Cells 8%
• Therapeutic Significance 8%
• John Walsh 8%
• Experimental Removal 8%

Medicine and Dentistry

• Lung 100%
• Cell Therapy 100%
• Stem Cell 100%
• Pulmonary Disorder 100%
• Progenitor Cell 38%
• Mesenchymal Stem Cell 33%
• Endothelial Progenitor Cell 28%
• Medicine 19%
• Cell Population 19%
• Clinical Trial 14%
• Human Embryonic Stem Cell 14%
• Diseases 14%
• Lung Cancer 9%
• Pulmonary Hypertension 9%
• Pulmonary Fibrosis 9%
• Crohn's Disease 9%
• Silo-Filler's Disease 9%
• Clara Cell 9%
• Lung Stem Cell 9%
• Biological Product 4%
• Ex Vivo 4%
• Cancer Stem Cell 4%
• Cystic Fibrosis 4%
• Cell Function 4%
• In Vitro 4%
• Pathophysiology 4%
• Engraftment 4%
• Translational Research 4%
• Stem Cell Niche 4%
• Secretory Protein 4%
• Epithelial Cell 4%
• Immunomodulation 4%
• Immunocompetent Cell 4%
• Respiratory Disease 4%
• Cell Regeneration 4%
• Muscle Disease 4%
• Acute Lung Injury 4%
• Cell Membrane Potential 4%
• Embryoid Body 4%
• Pulmonary Vasculature 4%
• Alveolar Epithelium 4%
• Lung Development 4%
• Physical Environment 4%
• Stem Cell Line 4%
• Amnion Fluid 4%
• Cyproterone Acetate Plus Ethinylestradiol 4%
• Side Population Cell 4%
• Graft Versus Host Reaction 4%
• Adult Stem Cell 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 100%
• Clinical Trial 20%
• Mouse Model 20%
• Lung Cancer 13%
• Lung Disease 13%
• Lung Fibrosis 13%
• Pulmonary Hypertension 13%
• Crohn's Disease 13%
• Graft Versus Host Reaction 6%
• Immunomodulation 6%
• Acute Lung Injury 6%
• Cystic Fibrosis 6%
• Biological Product 6%
• Muscle Disease 6%
• Respiratory Tract Disease 6%
• Secretory Protein 6%
• Cyproterone Acetate Plus Ethinylestradiol 6%
• Pathophysiology 6%